We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00262990
Recruitment Status : Completed
First Posted : December 7, 2005
Last Update Posted : May 4, 2012
Information provided by (Responsible Party):
Novartis ( Novartis Pharmaceuticals )